Aspire-Lakewood Holdings, Inc. (ASBP) vs Citius Pharmaceuticals, Inc. (CTXR)

Aspire-Lakewood Holdings, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. Aspire-Lakewood Holdings, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($12.6M and $12.1M). Citius Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −11,309.3%) and the lower return on invested capital (−58.7% vs 0.00%). Across the 14 metrics below, Citius Pharmaceuticals, Inc. leads on 8 and Aspire-Lakewood Holdings, Inc. on 6.

Valuation

Metric ASBP CTXR Biotechnology median
P/E 0.24 n/m 8.50
P/S 93.27 n/m 9.71
P/B 0.78 0.16 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales (2.70) n/m 9.21
Earnings yield 413.99% (372.09%) (33.15%)
Free cash flow yield (78.86%) (289.71%) (25.50%)

Profitability

Metric ASBP CTXR Biotechnology median
Gross margin (24.97%) 0.00% 65.16%
Operating margin (7,491.61%) 0.00% 0.00%
Net margin (11,309.31%) 0.00% 0.00%
Free cash flow margin (7,355.07%) 0.00% 0.00%
Return on equity (1,032.15%) (64.51%) (56.36%)
Return on assets (152.09%) (34.29%) (48.04%)
Return on invested capital 0.00% (58.74%) 0.00%

Growth

Metric ASBP CTXR Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (762.74%) 43.38% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ASBP CTXR Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 7.99 0.84 4.72
Net debt to EBITDA (0.16) 0.11 0.96

Dividend

Metric ASBP CTXR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ASBP CTXR Biotechnology median
Market cap 12.11m 12.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack